Joseph Cornell | PRION 2025 | Galoá Proceedings

School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA

Joseph Cornell

Is this your profile? Do login to access your certificates

Repurposing FDA-approved compounds as modulators of amyloidogenic aggregation in prion-like neurodegenerative disease models
Karpuj, Marcela-Viviana ¹
Cornell, Joseph ²
Chernoff, Yury ²
shimanovich, ulyana ³
BIZAT, Nicolas ⁴
¹ Braude College of Engineering karmiel
² School of Biological Sciences, Georgia Institute of Technology, Atlanta, GA, USA
³ Molecular Chemistry and Materials Science’ Weizmann Institute of Science, Rehovot, Israel
⁴ ICM Institute, Sorbonne University, France
Vol 1, 2025 -
327225

Therapeutic approaches for prion and prion-like diseases

Abstract Prion 2025

Co-authors (4)